Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Slides:



Advertisements
Similar presentations
Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Advertisements

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger  Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal.
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Constantin Stefanidis, MD, Albert M
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure
Clinical Outcomes of the David V Valve-Sparing Root Replacement Compared With Bioprosthetic Valve-Conduits for Aortic Root Aneurysms  Jiro Esaki, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Mitral Valve Surgery in the Adult Marfan Syndrome Patient
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Reoperation After Mitral Valve Repair for Degenerative Disease
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L
Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis
Operative Results and Outcomes in Children With Shone's Anomaly
Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery?  Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,
Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair
Outcomes of Early Mitral Valve Reoperation in the Medicare Population
Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch  Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,
Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement  Hyun-Chel Joo, MD,
Long-Term Outcomes of the Mosaic Bioprosthesis
Durability of Homografts Used to Treat Complex Aortic Valve Endocarditis  Willem Flameng, MD, PhD, Willem Daenen, MD, Ramadan Jashari, MD, Paul Herijgers,
Is the bentall procedure for ascending aorta or aortic valve replacement the best approach for long-term event-free survival?  Christian Hagl, MD, Justus.
Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité  Joerg Seeburger, MD, Volkmar Falk, MD, PhD,
Long-term results of aortic valve–sparing operations in patients with Marfan syndrome  Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.
Expanding Indications for Valve-Sparing Aortic Root Reconstruction: Early and Midterm Results  Johanna Valo, BM, Janne J. Jokinen, MD, PhD, Markku Kaarne,
Which Patients Benefit From Stentless Aortic Valve Replacement?
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E
Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid.
Long-Term Outcomes of Open Arch Repair After a Prior Aortic Operation: Our Experience in 154 Patients  Roberto Di Bartolomeo, MD, Paolo Berretta, MD,
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
John M. Stulak, MD, Joseph A. Dearani, MD, Harold M
Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M
Redo Aortic Valve Replacement in Children
Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival  Marc R. Moon, MD, Michael K. Pasque, MD, Nabil.
Nilto Carias de Oliveira, MD, Tirone E
Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M
Mohammad A. Zafar, MBBS, Emily A
Aortic Root Replacement for Children With Loeys-Dietz Syndrome
Midterm Outcome of Valve-Sparing Aortic Root Replacement in Inherited Connective Tissue Disorders  Hiroshi Tanaka, MD, PhD, Hitoshi Ogino, MD, PhD, Hitoshi.
Markus Liebrich, MD, Marcin K
Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve  Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD 
Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass
Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve  Marjan Jahangiri, FRCS, Jean Claude Laborde,
Mitroflow Synergy Prostheses for Aortic Valve Replacement: 19 Years Experience With 1,516 Patients  Kazutomo Minami, MD, Armin Zittermann, PhD, Sebastian.
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses  Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.
Complex Cusp Repair in Patients Undergoing the David Procedure: Is It Worth It?  Hardy Baumbach, MD, Kristina Wachter, MD, Ragi Nagib, MD, Samir Ahad,
Aortic valve replacement: comparison of late survival between autografts and homografts  Christopher J Knott-Craig, MD, Ronald C Elkins, MD, KathyLee.
Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study  Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,
Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J
Mitral Repair Versus Replacement for Ischemic Mitral Regurgitation
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
The Risk and Outcomes of Reoperative Tricuspid Valve Surgery
Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery  Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.
Right Minithoracotomy Versus Full Sternotomy for Mitral Valve Repair: A Propensity Matched Comparison  Rüdiger Lange, MD, PhD, Bernhard Voss, MD, Victoria.
Xiaoying Lou, MD, Edward P. Chen, MD, Yazan M. Duwayri, MD, Ravi K
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Wilson Y. Szeto, MD, Joseph E. Bavaria, MD, Frank W
Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement  Heinrich Koertke, MD,
Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W
Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter?  Asvin M. Ganapathi,
Risk of Valve-Related Events After Aortic Valve Repair
Richard J Kaplon, MD, Delos M Cosgrove, MD, A
Early and Late Outcomes of Aortic Valve Replacement in Dialysis Patients  Keisuke Tanaka, MD, Kazuyoshi Tajima, MD, Yoshiyuki Takami, MD, Noritaka Okada,
Presentation transcript:

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS, Manjula Maganti, MS  The Annals of Thoracic Surgery  Volume 90, Issue 3, Pages 775-781 (September 2010) DOI: 10.1016/j.athoracsur.2010.05.034 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier estimates of survival after aortic valve replacement with the Hancock II bioprosthesis according to age < 60 years (triangles), age 60 to 70 years (circles), and age > 70 years (squares). The Annals of Thoracic Surgery 2010 90, 775-781DOI: (10.1016/j.athoracsur.2010.05.034) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Freedom from structural valve deterioration is shown for (A) all patients (dotted lines on either side of solid line represent upper and lower 95% confidence intervals) and (B) according to age group. The Annals of Thoracic Surgery 2010 90, 775-781DOI: (10.1016/j.athoracsur.2010.05.034) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Freedom from reoperation due to structural valve deterioration is shown for (A) all patients (dotted lines on either side of solid line represent upper and lower 95% confidence interval) and (B) according to age group. The Annals of Thoracic Surgery 2010 90, 775-781DOI: (10.1016/j.athoracsur.2010.05.034) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions